HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.
Br J Cancer
; 87(8): 905-8, 2002 Oct 07.
Article
de En
| MEDLINE
| ID: mdl-12373607
ABSTRACT
The candidate prostate cancer susceptibility gene HPC2/ELAC2 has two common coding polymorphisms (Ser-->Leu 217) and (Ala-->Thr 541). The Thr541 variant in the HPC2/ELAC2 gene has previously been reported to be at an increased frequency in prostate cancer cases. To evaluate this hypothesis we genotyped 432 prostate cancer patients (including 262 patients diagnosed
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Polymorphisme génétique
/
Tumeurs de la prostate
/
Prédisposition génétique à une maladie
/
Mutation
/
Protéines tumorales
Type d'étude:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limites:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Br J Cancer
Année:
2002
Type de document:
Article
Pays d'affiliation:
Royaume-Uni